Arvee Laboratories (India) Ltd. (NSE:ARVEE)
India · Delayed Price · Currency is INR 158.61
-1.39 (-0.87%)
Jun 2, 2026, 3:31 PM IST
NSE:ARVEE Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 315.14 | 384.87 | 303.45 | 613.47 | 399.65 | |
Revenue Growth (YoY) | -18.12% | 26.83% | -50.53% | 53.50% | -15.64% |
Cost of Revenue | 146.64 | 206.85 | 147.02 | 394.48 | 224.4 |
Gross Profit | 168.5 | 178.02 | 156.43 | 218.99 | 175.25 |
Selling, General & Admin | 44.69 | 70.21 | 59.52 | 61.67 | 57.08 |
Other Operating Expenses | 91.84 | 71.69 | 67.54 | 84.51 | 65.02 |
Operating Expenses | 148.66 | 153.39 | 142.04 | 166.97 | 145.31 |
Operating Income | 19.84 | 24.62 | 14.39 | 52.02 | 29.94 |
Interest Expense | -2.35 | -1.51 | -1.88 | -2.86 | -3.15 |
Interest & Investment Income | - | 4.03 | 3.58 | 2.01 | 2.65 |
Currency Exchange Gain (Loss) | - | 1.14 | 1.48 | 11.35 | 3.63 |
Other Non Operating Income (Expenses) | 6.81 | -0.91 | 0.08 | -0.96 | -0.47 |
EBT Excluding Unusual Items | 24.31 | 27.38 | 17.65 | 61.56 | 32.6 |
Gain (Loss) on Sale of Investments | - | 1.34 | 0.64 | 0.08 | 1.24 |
Gain (Loss) on Sale of Assets | - | -0.01 | - | 0.01 | - |
Pretax Income | 24.31 | 28.71 | 18.3 | 61.65 | 34.49 |
Income Tax Expense | -0.96 | 7.24 | 7.78 | 20.46 | 8.75 |
Net Income | 25.26 | 21.47 | 10.52 | 41.19 | 25.74 |
Net Income to Common | 25.26 | 21.47 | 10.52 | 41.19 | 25.74 |
Net Income Growth | 17.65% | 104.15% | -74.46% | 60.04% | -3.87% |
Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 |
Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 |
Shares Change (YoY) | 0.11% | - | - | - | 29.28% |
EPS (Basic) | 2.29 | 1.95 | 0.95 | 3.74 | 2.34 |
EPS (Diluted) | 2.29 | 1.95 | 0.95 | 3.74 | 2.34 |
EPS Growth | 17.52% | 105.11% | -74.58% | 60.04% | -25.64% |
Free Cash Flow | -29.53 | -20.6 | 10.78 | 14.45 | -16.83 |
Free Cash Flow Per Share | -2.68 | -1.87 | 0.98 | 1.31 | -1.53 |
Gross Margin | 53.47% | 46.25% | 51.55% | 35.70% | 43.85% |
Operating Margin | 6.30% | 6.40% | 4.74% | 8.48% | 7.49% |
Profit Margin | 8.02% | 5.58% | 3.47% | 6.71% | 6.44% |
Free Cash Flow Margin | -9.37% | -5.35% | 3.55% | 2.35% | -4.21% |
EBITDA | 31.98 | 36.11 | 29.29 | 72.73 | 53.05 |
EBITDA Margin | 10.15% | 9.38% | 9.65% | 11.86% | 13.28% |
D&A For EBITDA | 12.14 | 11.49 | 14.9 | 20.71 | 23.12 |
EBIT | 19.84 | 24.62 | 14.39 | 52.02 | 29.94 |
EBIT Margin | 6.30% | 6.40% | 4.74% | 8.48% | 7.49% |
Effective Tax Rate | - | 25.20% | 42.51% | 33.19% | 25.37% |
Revenue as Reported | 321.95 | 391.44 | 309.85 | 626.99 | 407.9 |
Advertising Expenses | - | 0.27 | 0.23 | 0.31 | 0.17 |